{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:17:37Z","timestamp":1759342657475,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1016\/s0248-8663(02)00570-2","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T18:26:16Z","timestamp":1034101576000},"page":"357-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Syndrome des antiphospholipides avec anticorps antiphosphatidyl\u00e9thanolamine isol\u00e9s\u00a0: \u00e0 propos de 20 cas"],"prefix":"10.1016","volume":"23","author":[{"given":"C","family":"Desauw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Boumbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Bouroz-Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Ponard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Arvieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Dubucquoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L","family":"Fauchais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.Y","family":"Hatron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Devulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0248-8663(02)00570-2_BIB1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/jaut.2000.0401","article-title":"Which are the Best Biological Markers of the Antiphospholipid Syndrome ?","volume":"15","author":"Carreras","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/jaut.2000.0425","article-title":"Antiphosphatidylethanolamine antibodies : a survey","volume":"15","author":"McIntyre","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB3","first-page":"1375","article-title":"Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA : II. Kininogen reactivity","volume":"2","author":"Boffa","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/ard.48.2.166","article-title":"Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis","volume":"48","author":"Staub","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB5","first-page":"603","article-title":"Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibody in systemic lupus erythematosus with thrombosis","volume":"10","author":"Karmochkine","year":"1992","journal-title":"Clin Exp Rheum"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB6","first-page":"1369","article-title":"Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases","volume":"23","author":"B\u00e9rard","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0015-0282(16)58565-3","article-title":"Antiphospholipid antibody panels and recurrent pregnancy loss : prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies","volume":"66","author":"Yetman","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0015-0282(99)00119-3","article-title":"Prevalence and heterogeneity of antiphsphatidylethanolamine antibodies in patients with recurrent early pregnancy losses","volume":"71","author":"Sugi","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB9","first-page":"575","article-title":"Antiphospholipid antibodies in heart transplant recipients","volume":"18","author":"McIntyre","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0041-1345(98)01479-1","article-title":"Antiphospholipid antibodies in left-ventricular assist system recipients after exposure to topical bovine thrombine","volume":"31","author":"Fastenau","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preleminary classification criteria for definite antiphospholipid syndrome : report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB12","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants\u00a0: an update. On behalf of the Subcommitee on lupus anticoagulant\/antiphospholipid antibody on the scientific and standardisation Commitee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB13","first-page":"859","article-title":"Avortements \u00e0 r\u00e9p\u00e9tition, thromboses et anticoagulant circulant de type antithromboplastine","volume":"9","author":"Soulier","year":"1980","journal-title":"Nouv Presse M\u00e9d"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB14","first-page":"486","article-title":"The anticardiolipin syndrome","volume":"13","author":"Hughes","year":"1986","journal-title":"J Rheumatol"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(08)60777-4","article-title":"Immunology and clinical importance of antiphospholipid antibodies","volume":"49","author":"McNeil","year":"1991","journal-title":"Adv Immunol"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2340\/0001555571416422","article-title":"Lupus anticoagulant and the skin. A longterm follow-up study of patients with special reference to histopathological findings","volume":"71","author":"Stephansson","year":"1991","journal-title":"Acta Dermatol Venereol"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-1001891","article-title":"Cutaneous expressions of antiphopholipid syndromes","volume":"20","author":"Eng","year":"1994","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl. 2","key":"10.1016\/S0248-8663(02)00570-2_BIB18","first-page":"204","article-title":"Patients with antiphosphatidylethanolamine as the sole antiphospholipid antibody have clinical caracteristics of antiphospholipid antibody syndrome","volume":"7","author":"Wagenknecht","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0002-9343(92)90760-9","article-title":"Antiphospholipid antibodies and atherosclerosis","volume":"92","author":"Lecerf","year":"1992","journal-title":"Am J M"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB20","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/096120339600500522","article-title":"Antiphospholipid antibodies and atherosclerosis","volume":"5","author":"Vaarala","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1191\/096120300678828190","article-title":"Autoimmunity in atherosclerosis : lessons from experimental models","volume":"9","author":"George","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000028046","article-title":"Enhancement of atherosclerosis in \u00df2GPI immunized apolipoprotein E-deficient mice","volume":"67","author":"Afek","year":"1999","journal-title":"Pathobiology"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1177\/096120339700600701","article-title":"The anti-phospholipid (Hughes) syndrome : a crossroads of autoimmunity and atherosclerosis","volume":"6","author":"George","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/S0248-8663(02)00570-2_BIB24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/096120339700600908","article-title":"Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies","volume":"6","author":"George","year":"1997","journal-title":"Lupus"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866302005702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866302005702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:05:11Z","timestamp":1759334711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866302005702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0248866302005702"],"URL":"https:\/\/doi.org\/10.1016\/s0248-8663(02)00570-2","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2002,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome des antiphospholipides avec anticorps antiphosphatidyl\u00e9thanolamine isol\u00e9s\u00a0: \u00e0 propos de 20 cas","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0248-8663(02)00570-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 \u00c9ditions scientifiques et m\u00e9dicales Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}